The effect of chemically modified alginates on macrophage phenotype and biomolecule transport

J Biomed Mater Res A. 2016 Jul;104(7):1707-19. doi: 10.1002/jbm.a.35700. Epub 2016 Mar 18.

Abstract

Macrophage (MΦ) reprogramming has received significant attention in applications such as cancer therapeutics and tissue engineering where the host immune response to biomaterials is crucial in determining the success or failure of an implanted device. Polymeric systems can potentially be used to redirect infiltrating M1 MΦs toward a proangiogenic phenotype. This work exploits the concept of MΦ reprogramming in the engineering of materials for improving the longevity of tissue engineering scaffolds. We have investigated the effect of 13 different chemical modifications of alginate on MΦ phenotype. Markers of the M1 response-tumor necrosis factor-α (TNF-α) and inducible nitric oxide synthase-and the M2 response-arginase-were measured and used to determine the ability of the materials to alter MΦ phenotype. It was found that some modifications were able to reduce the pro-inflammatory response of M1 MΦs, others appeared to amplify the M2 phenotype, and the results for two materials suggested they were able to reprogram a MΦ population from M1 to M2. These findings were supplemented by studies done to examine the permselectivity of the materials. Diffusion of TNF-α was completely prevented through some of these materials, while up to 84% was found to diffuse through others. The diffusion of insulin through the materials was statistically consistent. These results suggest that the modification of these materials might alter mass transport in beneficial ways. The ability to control polarization of MΦ phenotypes with immunoprotective materials has the potential to augment the success of tissue engineering scaffolds. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1707-1719, 2016.

Keywords: alginate modification; biomolecule transport; islet encapsulation; macrophage reprogramming; tissue engineering.

MeSH terms

  • Alginates / chemistry*
  • Alginates / pharmacology*
  • Animals
  • Arginase / metabolism
  • Biological Transport / drug effects
  • Cattle
  • Diffusion
  • Enzyme-Linked Immunosorbent Assay
  • Glucuronic Acid / chemistry
  • Glucuronic Acid / pharmacology
  • Hexuronic Acids / chemistry
  • Hexuronic Acids / pharmacology
  • Insulin / metabolism
  • Interleukin-4 / pharmacology
  • Lipopolysaccharides / pharmacology
  • Macrophages / cytology*
  • Macrophages / drug effects
  • Mice
  • Nitric Oxide Synthase Type II / metabolism
  • Phenotype
  • RAW 264.7 Cells
  • Serum Albumin, Bovine / metabolism
  • Staining and Labeling
  • Static Electricity
  • Tumor Necrosis Factor-alpha / metabolism
  • Viscosity

Substances

  • Alginates
  • Hexuronic Acids
  • Insulin
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • Serum Albumin, Bovine
  • Glucuronic Acid
  • Nitric Oxide Synthase Type II
  • Arginase